Art
J-GLOBAL ID:200902228860078611   Reference number:03A0658037

Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

慢性腎臓病と高血圧症患者におけるアンギオテンシンII受容体きっ抗薬のロサルタンとカルシウムチャンネルブロッカーのアムロジピンの腎保護作用の中間証明:高血圧症患者のグローバル腎臓保護を意図した日本のロサルタン療法(JLIGHT)研究の報告
Author (9):
Material:
Volume:Issue:Page: 221-230  Publication year: Sep. 2003 
JST Material Number: L3173A  ISSN: 1342-1751  Document type: Article
Article type: 原著論文  Country of issue: Germany, Federal Republic of (DEU)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=03A0658037&from=J-GLOBAL&jstjournalNo=L3173A") }}
JST classification (3):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for urogenital diseases  ,  Clinical application of vasoactive drugs and hypotensive drugs  ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases 
Reference (24):
  • BURNIER, M. Comparative antihypertensive effects of angiotensin II receptor antagonists. J Am Soc Nephrol. 1999, 10, S278-282
  • BURNIER, R. Angiotensin receptor antagonists. Lancet. 2000, 355, 637-645
  • REMUZZI, G. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?. Kidney Int. 1990, 38, 384-394
  • POWRIE, JK. Microalbuminuria : should lowering albumin excretion be a therapeutic goal?. Int Clin Pract. 1999, 53, 492-493
  • FASSBINDER, W. Treatment with carvediol is associated with a significant reduction in microalbuminuria : a multicentre randomized study. Int J Clin Pract. 1999, 53, 519-522
more...

Return to Previous Page